Literature DB >> 28707052

Steered Molecular Dynamics for Investigating the Interactions Between Insulin Receptor Tyrosine Kinase (IRK) and Variants of Protein Tyrosine Phosphatase 1B (PTP1B).

Hung Nguyen1, Nhat Do2, Tuyn Phan3, Tri Pham3.   

Abstract

The aim of this study is to use steered molecular dynamics to investigate the dissociation process between IRK and PTP1Bs for wild type and five mutants (consisting of p.D181E, p.D181A, p.Q262A, p.D181A-Y46F, and p.D181A-Q262A). The gained results are observed not only the unbinding mechanism of IRK-PTP1B complexes came from pulling force profile, number of hydrogen bonds, and interaction energy between IRK and PTP1Bs but also described PTP1B's point mutations could variably change its binding affinity towards IRK. Additionally, the binding free energy calculated by Molecular Mechanics/Poisson-Boltzmann Surface Area (MM-PBSA) is also revealed that electrostatic energy and polar solvation energy mainly made up the binding free energy of PTP1B-IRK complexes.

Entities:  

Keywords:  Binding free energy; IRK-PTP1Bs; MM-PBSA; SMD

Mesh:

Substances:

Year:  2017        PMID: 28707052     DOI: 10.1007/s12010-017-2549-6

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  3 in total

1.  Antibody-nanobody combination increases their neutralizing activity against SARS-CoV-2 and nanobody H11-H4 is effective against Alpha, Kappa and Delta variants.

Authors:  Hung Nguyen; Mai Suan Li
Journal:  Sci Rep       Date:  2022-06-11       Impact factor: 4.996

2.  Calculating the absolute binding free energy of the insulin dimer in an explicit solvent.

Authors:  Qiankun Gong; Haomiao Zhang; Haozhe Zhang; Changjun Chen
Journal:  RSC Adv       Date:  2020-01-03       Impact factor: 4.036

3.  Investigation of Binding Affinity between Potential Antiviral Agents and PB2 Protein of Influenza A: Non-equilibrium Molecular Dynamics Simulation Approach.

Authors:  Tri Pham; Hoang Linh Nguyen; Tuyn Phan-Toai; Hung Nguyen
Journal:  Int J Med Sci       Date:  2020-07-25       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.